ONCOLYTICS BIOTECH INC
Pharmaceutical Preparations · SUITE 325, 4350 EXECUTIVE DRIVE, SAN DIEGO, CA 92121
官方登記資料
0位追蹤者
1998成立於
關於 ONCOLYTICS BIOTECH INC
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.
Source: Wikipedia
產業Pharmaceutical Preparations
總部SUITE 325, 4350 EXECUTIVE DRIVE, SAN DIEGO, CA 92121
成立時間1998
法律形式C Corporation
狀態營運中
專利19 項專利
T CELL REPERTOIRE DYNAMICS AND ONCOLYTIC VIRAL THERAPYJP2024177393A · 2024
LIQUID VIRAL FORMULATIONSJP2020015770A · 2020
關鍵數據
法律資訊
| 法定名稱 | ONCOLYTICS BIOTECH INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1129928在 SEC EDGAR 上查看 ↗ |
| EIN | 98-0541667 |
| 產業代碼(SIC) | 2834 |
| 登記地址 | SUITE 325, 4350 EXECUTIVE DRIVE, SAN DIEGO, CA 92121 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日
聯絡方式與連結
地點
SUITE 325, 4350 EXECUTIVE DRIVE, SAN DIEGO, CA 92121
這是你的公司嗎?
免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。
認領此頁面